ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P ASX 200
7,968.20
0.60%
S&P ASX All Technology
3,399.00
0.55%
Brent Oil
66.025
0.00%
US Dollar vs AUD
1.5603
0.00%
Bitcoin
94,687.13
-0.04%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Fortress Biotech Inc (FBIOP) Share Price

Fortress Biotech Inc

Fortress Biotech Inc (FBIOP)

NASDAQ
6.70
-0.04
(-0.593472%)
Closed 26 April 6:00AM
Delayed by 15 minutes
6.70
0.00
(0.00%)
After Hours: 6:02AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.70
Bid
6.45
Offer
7.00
Volume
9,630
6.63 Day's Range 6.92
0.00 52 Week Range 0.00
Market Cap
197.877M
Previous Close
6.74
Open
6.74
Last Trade
1
@
6.67
Last Trade Time
Financial Volume
US$ 64,875
VWAP
6.74
Average Volume (3m)
-
Shares Outstanding
29,533,840
Dividend Yield
34.98%
PE Ratio
-0.72
Earnings Per Share (EPS)
-2.33
Revenue
84.51M
Net Profit
-68.67M

About Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the g... Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.fortressbiotech.com
Headquarters
Dover, Delaware, USA
Founded
-
Fortress Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBIOP. The last closing price for Fortress Biotech was US$6.74. Over the last year, Fortress Biotech shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Fortress Biotech currently has 29,533,840 shares in issue. The market capitalisation of Fortress Biotech is US$199.06 million. Fortress Biotech has a price to earnings ratio (PE ratio) of -0.72.

Ask ADVFN Intelligence (AI)

FBIOP Latest News

More News

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
19 April 2025
FBIOP (-0.593472%)

Form 8-K - Current report
Edgar (US Regulatory)
17 April 2025
FBIOP (-0.593472%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
03 April 2025
FBIOP (-0.593472%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
03 April 2025
FBIOP (-0.593472%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
03 April 2025
FBIOP (-0.593472%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
03 April 2025
FBIOP (-0.593472%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 April 2025
FBIOP (-0.593472%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 April 2025
FBIOP (-0.593472%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

FBIOP - Frequently Asked Questions (FAQ)

What is the current Fortress Biotech share price?
The current share price of Fortress Biotech is US$ 6.70
How many Fortress Biotech shares are in issue?
Fortress Biotech has 29,533,840 shares in issue
What is the market cap of Fortress Biotech?
The market capitalisation of Fortress Biotech is USD 199.06M
What is the 1 year trading range for Fortress Biotech share price?
Fortress Biotech has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Fortress Biotech?
The price to earnings ratio of Fortress Biotech is -0.72
What is the cash to sales ratio of Fortress Biotech?
The cash to sales ratio of Fortress Biotech is 0.58
What is the reporting currency for Fortress Biotech?
Fortress Biotech reports financial results in USD
What is the latest annual turnover for Fortress Biotech?
The latest annual turnover of Fortress Biotech is USD 84.51M
What is the latest annual profit for Fortress Biotech?
The latest annual profit of Fortress Biotech is USD -68.67M
What is the registered address of Fortress Biotech?
The registered address for Fortress Biotech is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Fortress Biotech website address?
The website address for Fortress Biotech is www.fortressbiotech.com
Which industry sector does Fortress Biotech operate in?
Fortress Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WWWW International Inc
US$ 0.395
(167.62%)
223.58M
OMEXOdyssey Marine Exploration Inc
US$ 1.4979
(75.79%)
285.65M
RTCBaijiayun Group Ltd
US$ 0.3244
(74.88%)
263.23M
GREEGreenidge Generation Holdings Inc
US$ 1.3197
(53.92%)
5.84M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.28
(44.30%)
38.04M
CGTLCreative Global Technology Holdings Ltd
US$ 1.5197
(-75.09%)
3.88M
TOIIWOncology Institute Inc
US$ 0.1015
(-40.22%)
156.14k
COEPCoeptis Therapeutics Holdings Inc
US$ 7.70
(-38.25%)
716.99k
INTSIntesity Therapeutics Inc
US$ 0.56
(-37.78%)
3.21M
SMMTSummit Therapeutics Inc
US$ 23.47
(-36.05%)
24.67M
GNLNGreenlane Holdings Inc
US$ 0.012699
(-15.34%)
355.22M
AGMHAGM Group Holdings Inc
US$ 0.0477
(22.31%)
340.91M
OMEXOdyssey Marine Exploration Inc
US$ 1.4979
(75.79%)
285.65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.455
(19.62%)
266.95M
RTCBaijiayun Group Ltd
US$ 0.3244
(74.88%)
263.23M

Discussion

View Full Feed
nosfelle nosfelle 3 minutes ago
Cardano Users Can Now Earn Up TO 21% APY From Their Wallets
https://cryptonewsland.com/earn-up-to-21-apy/
ADAUSD
4u2nv2 4u2nv2 3 minutes ago
Why do you like me so much? Want my phone number? I am not single.
MCIC
Lime Time Lime Time 4 minutes ago
By now you are clueless how this OTC stock stuff works. By now your posts are laughable and completely clowns
GVSI
4u2nv2 4u2nv2 4 minutes ago
You got stuck reloading and want to blame me? Learn to trade.
MCIC
Tamboo Tamboo 5 minutes ago
Heading to $$$$$
GVSI
4u2nv2 4u2nv2 6 minutes ago
I have11,414 pieces of evidence that will show you slanderous statements.
MCIC
Chiugray Chiugray 6 minutes ago
I believe you are describing conditional approval, not confirmatory.
NWBO
Chiugray Chiugray 7 minutes ago
Attila, Agree. It is clear that the DCVax-L Phase 3 results are strong and points toward full approval for GBM, as the MAA application was submitted for.

If there is going to be any conditional approval, my guess is it would be an expanded label to treat Grade 3 brain tumors. Not sayi
NWBO
pgsd pgsd 8 minutes ago
NICE@NICEComms : "Our mission is to get the best treatments to people fast. The latest NHS Innovation Scorecard shows 73.1% of NICE-recommended treatments were prescribed more in 2024 than the year before"⤵️

https://x.com/peter_brit/status/1916001005814133108
NWBO
4u2nv2 4u2nv2 8 minutes ago
But you leave out the part that I posted those things to make you. Yes you. Happy. You are twisting words and leaving out key parts of sentences. Why attack me with false and misleading posts like this?
MCIC
4u2nv2 4u2nv2 11 minutes ago
Exactly. I am being stalked.
MCIC
Investor2014 Investor2014 13 minutes ago
Ah very good - some thinking alignment happening. Btw. did you just indirectly describe a "Precision Medicine" trial confirming label from subgroup analysis - you can have a cookie!
AVXL
OptimusPrime555 OptimusPrime555 15 minutes ago
Heading back to 0001 soon!  
SCAM run by SCUM! 😆🤣😂ZERO assets!         
ZERO revenues!         
ZERO financials!         
ZERO credibility CEO!         
ZERO share price coming!       
Delisting soon 👏
GVSI
Investor2014 Investor2014 15 minutes ago
You are forgetting the Anavex factor in between tre CHMP process days plus the handover to EMA for a final decision. Feb'ish maybe!
AVXL
Nebuchadnezzar Nebuchadnezzar 15 minutes ago
SPY ELLIOT WAVE

i believe this gentleman has been doing Elliot wave analysis for 50 years

no one is ever 100% accurate but he has a pretty good track record and gives great informatio

[

https://youtu.be/3eoqZL57rU8?si=8fmkzEut8IJluFnl
SPY
OptimusPrime555 OptimusPrime555 17 minutes ago
Bashers teaming up posting gibberish relentlessly and providing awesome hilarious entertainment! One of them just created a brand new bashing account lekavej571 few hours ago and of course other famous resident bashers GetPoorFast and Lime. Keep it coming. Looks like your bottoms are literally off w
AHRO
mrfence mrfence 17 minutes ago
The Warrants were issued by James Lockhart, as opposed to, to James Lockhart. They've bean received by da Gooberment. Just Sayin!
FNMA
TightCoil TightCoil 19 minutes ago
Fannie Mae - Keep The Fight Alive
Fight, Fight, Fight
Fight For What Is Right
Fight to Right the Wrongs Done to Shareholders
Justice - Freedom - Liberty - Honesty - America
FNMA
DollarDrone DollarDrone 29 minutes ago
Am trying to draw attention to the current  DOJ's Antitrust Policy Priorities shown in the link, but cant get the dadgum thing to work.
VPLM
johnhancoque johnhancoque 33 minutes ago
One thing that sincerely conflicts in me about NRSN is not only that absence of a signed partnership, but on the flip side the conspicuous absence of some sort of offering, financing or otherwise fund raise. The confusing part of this whole thing is the lack of money but the absence of something to
NRSN
DMC8 DMC8 38 minutes ago
Eicosapentaenoic acid (EPA) reduced lipopolysaccharide-stimulated inflammatory response of RAW264.7 cells via the miR-125b-5p/CREB axis
Available online 24 April 2025
https://www.sciencedirect.com/science/article/abs/pii/S0141813025040632
AMRN
DollarDrone DollarDrone 39 minutes ago
POLICY PRIORITIESNew DOJ Partial to Populist Antitrust
VPLM
DKLN DKLN 40 minutes ago
Wrong again, just like with this stock. It's free to look back at all previous posts and copy and paste them. There were numerous examples to choose from, but I thought that was a very good example. As for your accusation about having a subscription under two different posters, also wrong. What I th
MCIC
DollarDrone DollarDrone 41 minutes ago
POLICY PRIORITIESNew DOJ Partial to Populist Antitrust
VPLM
DollarDrone DollarDrone 46 minutes ago
Let's try this again:
 https://www.jdsupra.com/legalnews/antitrust-under-trump-april-2025-updates-7129307/
POLICY PRIORITIESNew DOJ Partial to Populist Antitrust
VPLM

Your Recent History

NASDAQ
FBIOP
Fortress Biotech
DOWI
DJDXAHUP
DJ Developed Markets ExA...
NASDAQ
CATSX
Columbia Strategic Munic...
TSXV
FISH.RT
Sailfish Royalty
NASDAQI
HX404010PI
OMX Helsinki Retailers PI
NASDAQ
CBFTX
Ci Alternative Diversifi...
ASX
AI1
Adisyn
COIN
MTCCCUST
Metacy
COIN
TESTTUST
Test
AMEX
LEU
Centrus Energy
ASX
BLGNA
Bluglass
NASDAQ
CBCJX
Canadian Equity Value Po...
TSXV
MIX
Micrex Development
DOWI
DJECONNT
DJ Emerging Markets Cons...
NASDAQ
WLDSW
Wearable Devices
TSXV
JPIM.WT
Jasper Commerce
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads